AI-guided de novo protein design — RFdiffusion backbone generation, ProteinMPNN sequence design, structure validation (pLDDT, pTM, MPNN scores). Use for designing therapeutic protein binders, novel scaffolds, enzyme variants, and miniprotein/protein-interface design before experimental validation.
Scanned 9/11/2026
Install to Claude Code
npx -y skills add huang-sh/DeepScience --skill tooluniverse-protein-therapeutic-design --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Tooluniverse Protein Therapeutic Design?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/huang-sh-tooluniverse-protein-therapeutic-design)More formats (shields.io, HTML) on the badges page.
---
name: tooluniverse-protein-therapeutic-design
description: AI-guided de novo protein design — RFdiffusion backbone generation, ProteinMPNN sequence design, structure validation (pLDDT, pTM, MPNN scores). Use for designing therapeutic protein binders, novel scaffolds, enzyme variants, and miniprotein/protein-interface design before experimental validation.
disable-model-invocation: true
---
# Therapeutic Protein Designer
AI-guided de novo protein design using RFdiffusion backbone generation, ProteinMPNN sequence optimization, and structure validation for therapeutic protein development.
**KEY PRINCIPLES**:
1. **Structure-first** - Generate backbone geometry before sequence
2. **Target-guided** - Design binders with target structure in mind
3. **Iterative validation** - Predict structure to validate designs
4. **Developability-aware** - Consider aggregation, immunogenicity, expression
5. **Evidence-graded** - Grade designs by confidence metrics
6. **Actionable output** - Provide sequences ready for experimental testing
7. **English-first queries** - Always use English terms in tool calls
Therapeutic protein design starts with the target interaction. What binding surface do you need to cover? A small pocket = nanobody or peptide. A large flat surface = designed protein. Stability, immunogenicity, and manufacturability constrain the design space.
## LOOK UP, DON'T GUESS
When uncertain about any scientific fact, SEARCH databases first rather than reasoning from memory. A database-verified answer is always more reliable than a guess.
---
## COMPUTE, DON'T DESCRIBE
When analysis requires computation (statistics, data processing, scoring, enrichment), write and run Python code via Bash. Don't describe what you would do — execute it and report actual results. Use ToolUniverse tools to retrieve data, then Python (pandas, scipy, statsmodels, matplotlib) to analyze it.
## When to Use
Apply when user asks to:
- Design a protein binder, therapeutic protein, or scaffold
- Optimize a protein sequence for function
- Design a de novo enzyme
- Generate protein variants for target binding
---
## Workflow Overview
```
Phase 1: Target Characterization
Get structure (PDB, EMDB cryo-EM, AlphaFold), identify binding epitope
Phase 2: Backbone Generation (RFdiffusion)
Define constraints, generate >= 5 backbones, filter by geometry
Phase 3: Sequence Design (ProteinMPNN)
Design >= 8 sequences per backbone, sample with temperature control
Phase 4: Structure Validation (ESMFold/AlphaFold2)
Predict structure, compare to backbone, assess pLDDT/pTM
Phase 5: Developability Assessment
Aggregation, pI, expression prediction
Phase 6: Report Synthesis
Ranked candidates, FASTA, experimental recommendations
```
---
## Critical Requirements
### Report-First Approach (MANDATORY)
1. Create `[TARGET]_protein_design_report.md` first with section headers
2. Progressively update as designs are generated
3. Output `[TARGET]_designed_sequences.fasta` and `[TARGET]_top_candidates.csv`
### Design Documentation (MANDATORY)
Every design MUST include: Sequence, Length, Target, Method, and Quality Metrics (pLDDT, pTM, MPNN score, binding prediction).
---
## NVIDIA NIM Tools
| Tool | Purpose | Key Parameter |
|------|---------|---------------|
| `NvidiaNIM_rfdiffusion` *(requires NVIDIA_API_KEY env var; free key at build.nvidia.com)* | Backbone generation | `diffusion_steps` (NOT `num_steps`) |
| `NvidiaNIM_proteinmpnn` *(requires NVIDIA_API_KEY env var; free key at build.nvidia.com)* | Sequence design | `pdb_string` (NOT `pdb`) |
| `ESMFold_predict_structure` | Fast validation | `sequence` (NOT `seq`) |
| `NvidiaNIM_alphafold2` *(requires NVIDIA_API_KEY env var; free key at build.nvidia.com)* | High-accuracy structure inference from sequence | `sequence`, `algorithm` |
| `NvidiaNIM_esm2_650m` *(requires NVIDIA_API_KEY env var; free key at build.nvidia.com)* | Sequence embeddings | `sequences`, `format` |
### Common Parameter Mistakes
| Tool | Wrong | Correct |
|------|-------|---------|
| `NvidiaNIM_rfdiffusion` *(requires NVIDIA_API_KEY)* | `num_steps=50` | `diffusion_steps=50` |
| `NvidiaNIM_proteinmpnn` *(requires NVIDIA_API_KEY)* | `pdb=content` | `pdb_string=content` |
| `ESMFold_predict_structure` | `seq="MVLS..."` | `sequence="MVLS..."` |
| `NvidiaNIM_alphafold2` *(requires NVIDIA_API_KEY)* | `seq="MVLS..."` | `sequence="MVLS..."` |
### NVIDIA NIM Requirements
- **API Key**: `NVIDIA_API_KEY` environment variable required
- **Rate limits**: 40 RPM (1.5 second minimum between calls)
- AlphaFold2 may return 202 (polling required); RFdiffusion and ESMFold are synchronous
---
## Supporting Tools
| Tool | Purpose | Key Parameters |
|------|---------|----------------|
| `PDBe_get_uniprot_mappings` | Find PDB structures | `uniprot_id` |
| `RCSBData_get_entry` | Download PDB file | `pdb_id` |
| `alphafold_get_prediction` | Get AlphaFold DB structure | `accession` |
| `EMDB_search_structures` | Search cryo-EM maps | `query` |
| `EMDB_get_structure` | Get entry details | `entry_id` |
| `UniProt_get_entry_by_accession` | Get target sequence | `accession` |
| `InterPro_get_protein_domains` | Get domains | `accession` |
---
## Evidence Grading
| Tier | Criteria |
|------|----------|
| T1 (best) | pLDDT >85, pTM >0.8, low aggregation, neutral pI |
| T2 | pLDDT >75, pTM >0.7, acceptable developability |
| T3 | pLDDT >70, pTM >0.65, developability concerns |
| T4 | Failed validation or major developability issues |
---
## Completeness Checklist
- [ ] Target structure obtained (PDB or predicted)
- [ ] Binding epitope identified
- [ ] >= 5 backbones generated, top 3-5 selected
- [ ] >= 8 sequences per backbone, MPNN scores reported
- [ ] All sequences validated (ESMFold), pLDDT/pTM reported, >= 3 passing
- [ ] Developability assessed (aggregation, pI, expression)
- [ ] Ranked candidate list, FASTA file, experimental recommendations
---
## Reference Files
- **DESIGN_PROCEDURES.md** - Phase-by-phase code examples, sampling parameters, fallback chains
- **TOOLS_REFERENCE.md** - Complete tool documentation with code examples
- **EXAMPLES.md** - Sample design workflows and outputs
- **CHECKLIST.md** - Detailed phase checklists and quality metrics
- **design_templates.md** - Report templates and output format examples
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!